On a Complex Biphasic Neoplasm Involving the Ovary and Omentum Expressing Neuroendocrine Markers, HBME1 and TTF1: A Case Report and the Literature Review

Abstract

A Case of Malignant Mixed Ovarian Tumor (OMMMT) with synchronous mesenteric localization presenting heterologous expression of neuroendocrine markers, mesothelin and TTFI is studied. The peculiarity of this case is that of presenting immunophenotypic characters not yet reported in the literature in OMMMT.

Keywords

Please add 3-8 keywords

CONFLICTS OF INTEREST DISCLOSURE

There is no conflict of interest.

References

[1] Soslow RA. Mixed Mûllerian Tumors of The Female Genital Tract. Surgical Pathology. 2009; 2: 707-730. PMid:26838776. https://doi.org/10.1016/j.path.2009.08.016

[2] Duman BB, Kara IO, Gunaldi M, et al. Malignant mixed Mûllerian tumour of the ovary with two cases and review of the literature. Arch Gynecol Obstet. 2011; 283: 1363-68. PMid:21298439.https://doi.org/10.1007/s00404-011-1845-6

[3] del Carmen MG, Birrer M, Schorge JO. Carcinosarcoma of the ovary: a review of the literarture. Gynecoloncol. 2012; 125: 271-77. PMid:22155675. https://doi.org/10.1016/j.ygyno.2011.12.418

[4] UÇAR MG, Çakır T, ILHAN TT, et al. Primary Ovarian Malignant Mixed Mûllerian Tumour: A Case Report and Brief Review of Literature. Journal of Clinical and Diagnostic Research. 2016; 10(3): QD04-QD06.

[5] Zhang PJ, Gao HG, Pasha TL, et al. TTF-1 Expression in Ovarian and Uterine Epithelial Neoplasia and its Potential Significance, an Immunohistochemical Assessment With Multiple Monoclonal Antibodies and Different Secondary Detection Systems International Journal of Gynecological Pathology. 2008; 28: 10-18. PMid:19047914. https://doi.org/10.1097/PGP.0b013e3181804bc6

[6] Van Hoeven KH, Hudock Ja, Woodruff JM, et al. Small cell Neuroendocrine carcinoma of endometrium. Int. Journ. Gynec. Pathol. 1995; 14: 21-29 (10 casi). PMid:7883422. https://doi.org/10.1097/00004347-199501000-00005

[7] Toptas T, Tasova-Yildirim G, Karaveli ST, et al. Malignant mixed Müllerian tumor with small cell neuroendocrine differentiation: a case report and review of the literature. Eur. J. Gynaec. Oncol. 2014; 2. PMid:24716055. https://doi.org/10.1155/2014/948908

[8] Ribeiro-Silva A, Novello-Vilar A, Cunha A, et al. Malignant mixed Mullerian tumor of the uterine cervix with neuroendocrine differentiation. Int J Gynecol Cancer. 2002; 12: 223-227. PMid:11975686. https://doi.org/10.1046/j.1525-1438.2002.01100.x

[9] Munakata Iwai E, Tanaka N. Malignant Müllerian Mixed Tumor of the Uterine Cervix with a Small Cell Neuroendocrine Carcinoma Component. Case Reports in Patholog. 2013: 5. PMid:23533892. https://doi.org/10.1155/2013/630859

[10] Cokelaere K, Michielsen P, De Vo R, et al. Primary Mesenteric Malignant Mixed Mesodermal (Müllerian) Tumor with Neuroendocrine Differentiation. Mod Pathol. 2001; 14(5): 515-520. PMid:11353063. https://doi.org/10.1038/modpathol.3880340

[11] Ma CJ, Yang SF, Huang CC, et al. Malignant mixed müllerian tumor of primary mesenteric origin associated with a synchronous ovarian cancer: case report and literature review. Eur. J. Gynaec. Oncol. 2008; 3(1 caso).

[12] Huang CC, Ma CJ, Huang WT, et al. Malignant mixed Müllerian tumor arising from the mesorectum with a synchronous ovarian cancer: a case report and review of the literature. Huang et al. Journal of Medical Case Reports. 2011; 5: 15. PMid:21244653. https://doi.org/10.1186/1752-1947-5-15

[13] Hassan R, Kreitman RJ, Pastan I, et al. Localization of Mesothelin in Epithelial Ovarian Cancer. Appl Immunohistochem Mol Morphol. 2005; 13: 243-247. PMid:16082249. https://doi.org/10.1097/01.pai.00000141545.36485.d6

[14] McCluggage WG. Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas? J Clin Pathol. 2002; 55: 321-325. PMid:11986333. https://doi.org/10.1136/jcp.55.5.321